Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2003 2
2005 1
2006 2
2007 2
2008 2
2009 2
2011 3
2012 5
2013 5
2014 3
2015 8
2016 9
2017 7
2018 5
2019 8
2020 8
2021 12
2022 10
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet.
Stefanolo JP, Segura V, Grizzuti M, Heredia A, Comino I, Costa AF, Puebla R, Temprano MP, Niveloni SI, de Diego G, Oregui ME, Smecuol EG, de Marzi MC, Verdú EF, Sousa C, Bai JC. Stefanolo JP, et al. Among authors: sousa c. World J Gastroenterol. 2024 Mar 21;30(11):1545-1555. doi: 10.3748/wjg.v30.i11.1545. World J Gastroenterol. 2024. PMID: 38617446 Free PMC article. Clinical Trial.
Thiazolyl-isatin derivatives: Synthesis, in silico studies, in vitro biological profile against breast cancer cells, mRNA expression, P-gp modulation, and interactions of Akt2 and VIM proteins.
Freitas LAB, Sousa C, Lima BS, Duarte D, Gomes PATM, Ramos CGC, Costa VCM, Pitta MGDR, Rêgo MJBM, de Simone CA, Videira M, Leite ACL. Freitas LAB, et al. Among authors: sousa c. Chem Biol Interact. 2024 May 1;394:110954. doi: 10.1016/j.cbi.2024.110954. Epub 2024 Mar 20. Chem Biol Interact. 2024. PMID: 38518852
Clinical utility of urinary gluten immunogenic peptides in the follow-up of patients with coeliac disease.
Garzón-Benavides M, Ruiz-Carnicer Á, Segura V, Fombuena B, García-Fernandez F, Sobrino-Rodriguez S, Gómez-Izquierdo L, Montes-Cano MA, Millan-Domínguez R, Del Carmen Rico M, González-Naranjo C, Bozada-García JM, Coronel-Rodríguez C, Espin B, Díaz J, Comino I, Argüelles-Arias F, Cebolla Á, Romero-Gómez M, Rodriguez-Herrera A, Sousa C, Pizarro-Moreno Á. Garzón-Benavides M, et al. Among authors: sousa c. Aliment Pharmacol Ther. 2023 May;57(9):993-1003. doi: 10.1111/apt.17417. Epub 2023 Mar 8. Aliment Pharmacol Ther. 2023. PMID: 36890679
92 results